Ticker League

EBITDA for Stryker (SYK)

Latest filings through · Reported

Metric

TTM

$5.85B

YoY change

+27.9%

5Y CAGR

+15.4%

Peak year (2025)

$6.31B

EBITDA history chart for Stryker (SYK) from 1985 to 2025

Latest: $6.31B

EBITDA growth chart for Stryker (SYK) from 1985 to 2025

Latest: +27.9%

EBITDA history table for Stryker (SYK) from 1985 to 2025

  • 2025$6.31B+27.9%
  • 2024$4.94B-2.4%
  • 2023$5.06B+25.9%
  • 2022$4.02B+11.4%
  • 2021$3.61B+17.1%
  • 2020$3.08B-15.1%
  • 2019$3.63B+8.5%
  • 2018$3.34B+13.2%
  • 2017$2.95B+9.5%
  • 2016$2.69B+20.3%
  • 2015$2.24B+35.7%
  • 2014$1.65B+2.3%
  • 2013$1.61B-21.2%
  • 2012$2.05B-9.4%
  • 2011$2.26B+2.0%
  • 2010$2.22B+9.6%
  • 2009$2.02B+1.3%
  • 2008$2.00B+13.6%
  • 2007$1.76B+21.7%
  • 2006$1.45B+15.4%
  • 2005$1.25B+28.5%
  • 2004$974.70M+8.2%
  • 2003$901.00M+20.0%
  • 2002$750.80M+16.5%
  • 2001$644.60M+7.6%
  • 2000$599.00M+13.6%
  • 1999$527.50M+117.9%
  • 1998$242.10M+3.7%
  • 1997$233.50M+38.2%
  • 1996$168.90M-9.2%
  • 1995$186.00M+31.5%
  • 1994$141.40M+30.8%
  • 1993$108.10M+27.0%
  • 1992$85.10M+34.4%
  • 1991$63.30M+47.9%
  • 1990$42.80M+12.6%
  • 1989$38.00M+17.3%
  • 1988$32.40M+23.7%
  • 1987$26.20M+18.6%
  • 1986$22.10M+25.6%
  • 1985$17.60M—

EBITDA values are taken from Stryker's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Stryker (SYK)

According to Stryker's latest reported financial statements, the company's current EBITDA (TTM) is $5.85B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Stryker (SYK) most recent annual EBITDA stands at $6.31B (2025) – grew 27.9% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Stryker EBITDA compounded at +15.4% per year, with mixed annual results across the window.

$6.31B stands as the all-time-high annual EBITDA, posted in 2025, against a low of $17.60M during 1985.

Stryker EBITDA by Year

Stryker EBITDA 2025: $6.31B

Stryker posted EBITDA of $6.31B in 2025, grew 27.9% from 2024. This figure represents the highest annual value in the available history.

Stryker EBITDA 2024: $4.94B

In 2024, Stryker reported EBITDA of $4.94B, edged down 2.4% below 2023.

Stryker EBITDA 2023: $5.06B

Stryker EBITDA in 2023 was $5.06B, grew 25.9% from 2022.

Stryker EBITDA 2022: $4.02B

2022's EBITDA for Stryker came in at $4.02B, grew 11.4% from 2021.

Stryker EBITDA 2021: $3.61B

Stryker EBITDA in 2021 was $3.61B.

See more financial history for Stryker (SYK).

Sector peers by EBITDA

Healthcare peers of Stryker (SYK), ranked by their latest EBITDA

Frequently asked questions

Stryker (SYK) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview